Answers are grounded in this paper and cite their sources.
Evaluates albumin-globulin ratio as a predictive biomarker for chemotherapy response in triple-negative breast cancer, suggesting potential clinical utility.
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer. Pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) strongly correlates with significantly better long-term survival. However, affordable and easily accessible biomarkers to predict response are lacking. Serum albumin-globulin ratio (AGR), a measure of nutritional status and systemic inflammation has shown promise as a predictive marker in various malignancies.
No takes yet. Share an insight, caveat, or question.
Roy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: